台股 » 個股 » 台康生技 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台康生技

(6589)
可現股當沖
  • 股價
    60.5
  • 漲跌
    ▲2.6
  • 漲幅
    +4.49%
  • 成交量
    643
  • 產業
    上櫃 生技醫療類股▲0.37%
  • 524人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
台康生技 (6589)籌碼相關-大昌-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1202/2403/0603/1803/2804/1004/125060708090May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

大昌-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/07164.9000.0064.9014700.21%
2025/03/31173.0000.0069.8014920.20%
2025/03/28274.9500.0074.5024890.41%
2025/03/27177.5000.0077.2014940.20%
2025/03/2000.00177.5078.30-1620-0.16%
2025/03/14274.55274.9075.6008750.00%
2025/03/10176.1000.0076.7019160.11%
2025/03/05177.8000.0077.8019970.10%
2025/02/1400.00282.2081.90-21,080-0.19%
2025/02/12280.7000.0080.7021,0930.18%
2025/02/0700.00783.2683.50-71,116-0.63%
2025/02/0500.00381.4080.90-31,159-0.26%
2025/01/2200.00178.4080.50-11,237-0.08%
2025/01/21277.8500.0076.3021,2310.16%
2025/01/1500.00177.9079.00-11,241-0.08%
2025/01/0900.00375.2375.80-31,203-0.25%
2025/01/0800.00274.2574.90-21,190-0.17%
2025/01/0600.00173.8074.00-11,188-0.08%
2025/01/0300.00672.1772.80-61,176-0.51%
2024/12/30170.70171.5071.5001,1640.00%
2024/12/27171.60272.5070.90-11,164-0.09%
2024/12/2600.00272.0071.40-21,179-0.17%
2024/12/24271.4000.0070.9021,2050.17%
2024/12/20172.0000.0071.7011,2330.08%
2024/12/19173.00173.4073.1001,2520.00%
2024/12/1700.00372.6074.60-31,244-0.24%
2024/12/16469.33169.2069.5031,2230.25%
2024/12/13171.0000.0068.0011,1860.08%
2024/12/12374.4000.0073.5031,1100.27%
2024/12/101082.900.182.9082.909.99451.05%
2024/12/0900.00992.4792.10-9932-0.97%
2024/12/06690.4000.0090.2069140.66%
2024/12/05391.9000.0091.5039020.33%
2024/12/0400.00393.1092.30-3899-0.33%
2024/12/03391.8000.0092.2038950.34%
2024/11/2900.00295.0094.20-2845-0.24%
2024/11/28192.50393.0092.10-2812-0.25%
2024/11/27391.70992.8791.10-6797-0.75%
2024/11/21187.90388.9389.80-2741-0.27%
2024/11/19186.8000.0086.6017380.14%
2024/11/15288.70188.6088.7017350.14%
2024/11/14389.50591.3689.00-2738-0.27%
2024/11/1300.00689.7089.50-6736-0.81%
2024/11/12688.1500.0089.4067360.81%
2024/11/11390.7000.0090.7037230.41%
2024/11/07692.0000.0091.7067180.84%
2024/11/0600.00192.9093.10-1710-0.14%
2024/11/0500.00194.6094.10-1691-0.14%
2024/11/04393.30394.9092.6006900.00%
2024/11/01391.20395.2091.8006800.00%
2024/10/30293.75194.0093.0016580.15%
2024/10/2900.00592.3291.60-5635-0.79%
2024/10/2300.002388.1288.00-23568-4.05%
2024/10/1700.00385.3084.50-3613-0.49%
2024/10/11585.2200.0084.5056750.74%
2024/10/0400.00188.5087.40-1720-0.14%
2024/09/30188.90790.7488.80-6752-0.80%
2024/09/27287.05487.3587.60-2766-0.26%
2024/09/2300.00492.5094.00-4937-0.43%
2024/09/1800.001386.3488.80-13962-1.35%
2024/09/1600.00783.9484.20-7962-0.73%
2024/09/1300.001183.4183.00-11981-1.12%
2024/09/1200.00183.2083.00-1992-0.10%
2024/09/10183.401083.9282.70-91,021-0.88%
2024/09/06282.4500.0082.8021,0540.19%
2024/09/05284.1500.0082.5021,1370.18%
2024/08/3000.00485.6085.90-41,216-0.33%
2024/08/23184.40184.9084.6001,2280.00%
2024/08/22184.8000.0084.6011,2290.08%
2024/08/21185.6000.0085.5011,2290.08%
2024/08/0500.00477.6377.30-41,200-0.33%
2024/07/2200.00190.2089.00-11,144-0.09%
2024/07/170.194.10395.1094.30-2.91,101-0.26%
2024/07/0800.00194.0093.40-11,066-0.09%
2024/07/03195.0000.0094.9011,0220.10%
2024/07/01294.35493.9096.50-2891-0.22%
2024/06/28290.30190.4090.5018040.12%
2024/06/27489.58388.2088.0017810.13%
2024/06/26190.70191.8090.6007560.00%
2024/06/2400.00287.1086.10-2694-0.29%
2024/06/18385.23386.1085.1006500.00%
2024/06/17285.00284.9085.0006500.00%
2024/06/14384.0300.0084.0036430.47%
2024/06/1300.00184.0083.90-1637-0.16%
2024/06/12184.60188.4084.5006220.00%
2024/06/0700.002078.7578.50-20490-4.08%
2024/05/17182.9000.0083.1015580.18%
2024/05/16181.8000.0081.2015530.18%
2024/04/12285.3000.0085.3026390.31%
〈熱門股〉台康生技美國FDA藥證申請未過 周跌逾2成Anue鉅亨-2024/12/14
台康抗癌生物相似性藥獲歐盟 CHMP 推薦 有望第4季上市UDN聯合新聞網-2023/09/18
台康生技 相關文章
台康生技 相關影音